UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042241
Receipt number R000048211
Scientific Title Study of the prevalence of celiac disease in patients with T1DM in our hospital
Date of disclosure of the study information 2020/11/01
Last modified on 2023/05/01 17:44:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the prevalence of celiac disease in patients with T1DM in our hospital

Acronym

Prevalence of celiac disease in patients with T1DM

Scientific Title

Study of the prevalence of celiac disease in patients with T1DM in our hospital

Scientific Title:Acronym

Prevalence of celiac disease in patients with T1DM

Region

Japan


Condition

Condition

celiac disease

Classification by specialty

Gastroenterology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to reveal the prevalence of celiac disease in patients with T1DM in our hospital

Basic objectives2

Others

Basic objectives -Others

to reveal the clinical background of the patients with both T1DM and celiac disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

anti-tissue transglutaminase IgA antibody

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients with T1DM treated in our hospital

Key exclusion criteria

nothing

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Ohara

Organization

Hyogo Prefectural Harima-Himeji General Medical Center

Division name

Department of Diabetes and Endocrinology

Zip code

670-8560

Address

264-3, Kamiya-cho, Himeji, Hyogo

TEL

079-289-5080

Email

yuki29n29@yahoo.co.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Ohara

Organization

Hyogo Prefectural Harima-Himeji General Medical Center

Division name

Department of Diabetes and Endocrinology

Zip code

670-8560

Address

264-3, Kamiya-cho, Himeji, Hyogo

TEL

079-289-5080

Homepage URL


Email

oohara@hp.pref.hyogo.jp


Sponsor or person

Institute

Hyogo Prefectural Harima-Himeji General Medical Center

Institute

Department

Personal name



Funding Source

Organization

Shimane University School of Medicine

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Shimane University School of Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo Prefectural Harima-Himeji General Medical Center

Address

264-3, Kamiya-cho, Himeji, Hyogo

Tel

079-289-5080

Email

oohara@hp.pref.hyogo.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

115

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 11 Month 01 Day

Date of IRB

2020 Year 06 Month 10 Day

Anticipated trial start date

2020 Year 11 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective study


Management information

Registered date

2020 Year 10 Month 26 Day

Last modified on

2023 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048211


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name